Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation

Hiroshi Kanoe(Kyoto University), Junya Toguchida(Kyoto University), Hiroshi Yamamoto(Komatsu University), Taisuke Hosaka(Kyoto University), Hiroshi Murakami(The University of Tokyo), David Ron(Institute for Medical Research), Takashi Nakamura(Keio University), Tomitaka Nakayama(Kyoto University), Yasuaki Nakashima(University of Fukui), Masao S. Sasaki(Kyoto University), Tadao Tsuboyama(Kyoto University)
Oncogene
January 21, 1999
10.1038/sj.onc.1202364
Cited by 68

Related Papers

Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k
ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function
|Neuron|2015|917
The molecular basis for selective inhibition of unconventional mRNA splicing by an IRE1-binding small molecule
|Proceedings of the National Academy of Sciences|2012|594
Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases
|Cancer|1986|417
Increased sensitivity to dextran sodium sulfate colitis in IRE1β-deficient mice
|Journal of Clinical Investigation|2001|401